FDA Brief: Week of Feb 15, 2016

biosimilar

WHAT: Continuing Education Course for health care professionals  to strengthen knowledge and understanding of biosimilars and interchangeable products – which are not generic products

WHY: Growing interest in biosimilars and interchangeable products in the pharmaceutical industry

HOW: Will inform about the development process, approval pathways, and  relationships between biosimilars and interchangeable products.

LINK


Leave a Reply


Fill in your details below or click an icon to log in:

WordPress.com Logo



You are commenting using your WordPress.com account.
Log Out / 
Change )

Google photo



You are commenting using your Google account.
Log Out / 
Change )

Twitter picture



You are commenting using your Twitter account.
Log Out / 
Change )

Facebook photo



You are commenting using your Facebook account.
Log Out / 
Change )

Connecting to %s